In reply to Letter to the Editor from Paudel: Comment on "Changes in iPSC-Astrocyte Morphology Reflect Alzheimer's Disease Patient Clinical Markers".
作者信息
Buckley Noel J, Rowland Helen A
机构信息
Department of Psychiatry, University of Oxford, Oxford OX3 7JX, United Kingdom.
Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford OX1 3QU, United Kingdom.
出版信息
Stem Cells. 2025 Jun 24;43(7). doi: 10.1093/stmcls/sxaf031.
Abstract
摘要
相似文献
1
In reply to Letter to the Editor from Paudel: Comment on "Changes in iPSC-Astrocyte Morphology Reflect Alzheimer's Disease Patient Clinical Markers".
Stem Cells. 2025 Jun 24;43(7). doi: 10.1093/stmcls/sxaf031.
2
Changes in iPSC-astrocyte morphology reflect Alzheimer's disease patient clinical markers.
Stem Cells. 2025 Mar 10;43(3). doi: 10.1093/stmcls/sxae085.
3
Comment on "Changes in iPSC-Astrocyte Morphology Reflect Alzheimer's Disease Patient Clinical Markers".
Stem Cells. 2025 Jun 24;43(7). doi: 10.1093/stmcls/sxaf030.
4
Selegiline for Alzheimer's disease.
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
5
Nimodipine for primary degenerative, mixed and vascular dementia.
Cochrane Database Syst Rev. 2002(3):CD000147. doi: 10.1002/14651858.CD000147.
6
Donepezil for dementia due to Alzheimer's disease.
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
7
Nimodipine for primary degenerative, mixed and vascular dementia.
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.
8
Lecanemab in Early Alzheimer's Disease.
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
9
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
NIH Consens State Sci Statements. 2010 Apr 28;27(4):1-30.
10
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
本文引用的文献
1
Changes in iPSC-astrocyte morphology reflect Alzheimer's disease patient clinical markers.
Stem Cells. 2025 Mar 10;43(3). doi: 10.1093/stmcls/sxae085.
2
Induction of astrocyte reactivity promotes neurodegeneration in human pluripotent stem cell models.
Stem Cell Reports. 2024 Aug 13;19(8):1122-1136. doi: 10.1016/j.stemcr.2024.07.002. Epub 2024 Aug 1.
3
iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype.
J Neuroinflammation. 2024 Jan 4;21(1):7. doi: 10.1186/s12974-023-02951-2.
4
Astrocytic APOE4 genotype-mediated negative impacts on synaptic architecture in human pluripotent stem cell model.
Stem Cell Reports. 2023 Sep 12;18(9):1854-1869. doi: 10.1016/j.stemcr.2023.08.002. Epub 2023 Aug 31.
5
Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia.
Alzheimers Dement. 2023 Dec;19(12):5860-5871. doi: 10.1002/alz.13390. Epub 2023 Aug 31.
6
Artificial intelligence-based diagnosis of Alzheimer's disease with brain MRI images.
Eur J Radiol. 2023 Aug;165:110934. doi: 10.1016/j.ejrad.2023.110934. Epub 2023 Jun 20.
7
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.
Brain Commun. 2022 Oct 21;4(6):fcac267. doi: 10.1093/braincomms/fcac267. eCollection 2022.
8
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.
Cell. 2022 Jun 23;185(13):2213-2233.e25. doi: 10.1016/j.cell.2022.05.017.
9
Astrocytes Derived from Familial and Sporadic Alzheimer's Disease iPSCs Show Altered Calcium Signaling and Respond Differently to Misfolded Protein Tau.
Cells. 2022 Apr 22;11(9):1429. doi: 10.3390/cells11091429.
10
Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors.
Neuron. 2021 Nov 3;109(21):3402-3420.e9. doi: 10.1016/j.neuron.2021.08.003. Epub 2021 Sep 1.
Zotero 插件